Basilea Receives Complete Response Letter for Ceftobiprole – Zenopa

6 Basilea receives complete response letter for ceftobiprole   Zenopa
TopNews United States
 Basilea receives complete response letter for ceftobiprole   Zenopa
Basilea receives complete response letter for ceftobiprole
Zenopa
Earlier this month, Basilea revealed that its chronic hand eczema treatment Toctino was cleared for use in 15 EU countries.
FDA issues ceftobiprole Complete Response LetterCNNMoney.com (press release)
Data Monitoring Deficiencies Sink Ceftobiprole Once AgainBioWorld Online

all 82 news articles »


Comments are closed.